1. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)
Journal: Volume 15, Issue 6, June 2013
Authors: Bourin, P.; Bunnell, B.A.; Casteilla, L.; Dominici, M.; Katz, A.J.; March, K.L.; Redl, H.; Rubin, J.P.; Yoshimura, K.; Gimble, J.M.
2. The mesenchymal stromal cells dilemma-does a negative phase III trial of random donor mesenchymal stromal cells in steroid-resistant graft-versus-host disease represent a death knell or a bump in the road?
Journal: Volume 15, Issue 1, January 2013
Author: Galipeau, J.
3. Immunological characterization of multipotent mesenchymal stromal cells-The International Society for Cellular Therapy (ISCT) working proposal
Journal: Volume 15, Issue 9, September 2013
Authors: MSC Committee of the International Society for Cellular Therapy (ISCT); Krampera, M.; Galipeau, J.; Shi, Y.; Tarte, K.; Sensebe, L.
4. Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: Production process, content and identification of active components
Journal: Volume 14, Issue 5, May 2012
Authors: Fekete, N.; Gadelorge, M.; Fürst, D.; Maurer, C.; Dausend, J.; Fleury-Cappellesso, S; Mailnder, V.; Lotfi, R.; Ignatius, A.; Sensebe, L.; Bourin, P. ; Schrezenmeier, H.; Rojewski, M.T.
5. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing
Journal: Volume 14, Issue 2, February 2012
Authors: Francois, M.; Copland, I.B.; Yuan, S.; Romieu-Mourez, R.; Waller, E.K.; Galipeau, J.
6. Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: A long-term safety study
Journal: Volume 14, Issue 1, January 2012
Author: Mazzini, L.; Kareschi, K.; Ferrero, I.; Miglioretti, M.; Stecco, A.; Servo, S.; Carriero, A.; Monaco, F.; Fagioli, F.
7. Risk of tumorigenicity in mesenchymal stromal cell-based therapies - Bridging scientific observations and regulatory viewpoints
Journal: Volume 15, Issue 7, July 2013
Authors: Barkholt, L.; Flory, E.; Jekerle, V.; Lucas-Samuel, S.; Ahnert, P.; Bisset, L.; Buscher, D.; Fibbe, W.; Foussat, A.; Kwa, M.; Lantz, O.; Maciulaitis, R.; Palomaki, T.; Schneider, C.K.; Sensebe, L.; Tachdjian, G.; Tarte, K.; Tosca, L.; Salmikangas, P.
8. Phase I trial: The use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia
Journal: Volume 16, Issue 2, February 2014
Authors: Bura, A., Planat-Benard, V.; Bourin, P.; Silvestre, J.S.; Gross, F.; Grolleau, J.L.; Saint-Lebese, B.; Peyrafitte, J.A.; Fleury, S.; Gadelorge, M.; Taurand, M.; Dupuis-Coronas, S.; Leobon, B.; Casteilla, L.
9. Mesenchymal stromal cells and fibroblasts: A case of mistaken identity?
Journal: Volume 14, Issue 5, May 2012
Author: Hematti, P.
10. Is CD34 truly a negative marker for mesenchymal stromal cells?
Journal: Volume 14, Issue 10, November 2012
Authors: Lin, C.S.; Ning, H.; Lin, G.; Lue, T.F.